A laboratory technician at the Synthetic Biology and Biosurveillance Branch at the U.S. Army Medical Research Institute of Infectious Diseases demonstrates the Biodefense Mass Sequencing and Surveillance assay, developed by a team of researchers under the direction of branch chief Lt. Col. Jeffrey Kugelman during the coronavirus pandemic as a way to rapidly test large numbers of Service Members for exposure to COVID-19. BMASS can be used to test for multiple diseases at the same time, extending its potential beyond just COVID-19 surveillance. (DOD photo by: Paul Lagasse)
Photo posted on LinkedIn of Cassandra Simmons-Brown, the principal director of the Office of the Deputy Assistant Secretary of Defense for Chemical and Biological Defense, and DASD Ian Watson at CASSIE’s inauguration.
(Photo by Garry McLeod/LLNL)
The Pentagon’s 2023 Biodefense Posture Review recommended that the department more effectively communicate the risks posed by specific foreign investments.